NOVARTIS FDA Approval ANDA 084811

ANDA 084811

NOVARTIS

FDA Drug Application

Application #084811

Application Sponsors

ANDA 084811NOVARTIS

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL100MG;50MG0APRESAZIDEHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

FDA Submissions

ORIG1AP1976-05-26
LABELING; LabelingSUPPL19AP1989-03-06
LABELING; LabelingSUPPL23AP1991-06-20
LABELING; LabelingSUPPL25AP1992-02-21
LABELING; LabelingSUPPL26AP1992-11-04
LABELING; LabelingSUPPL27AP1993-04-07
LABELING; LabelingSUPPL28AP1996-01-30

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 84811
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.